Effect of l-carnitine supplementation on clinical symptoms in women with osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial
Notes for this study:
|Values||Pain. Placebo: before 9.16±4.85, after 7.19±4.43. Carnitine: before 10.63±3.62, after 4.87±3.37.|
|Trial Design||Randomized trial|
|Trial Length||1-6 months|
|Number of Subjects||72|
In a randomized, double-blind, placebo-controlled trial, 72 participants with mild to moderate knee osteoarthritis took 750 mg of l-carnitine tartrate or placebo daily for 8 weeks.
The total score on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was improved considerably more than in the placebo group. This was derived from improvements in pain, stiffness, and physical function.
Participants didn't report any adverse events.